After a DPhil in Chemistry at the University of Oxford and Post Docs at the University of Manchester and Institute of Cancer Research, Tim gained experience as a medicinal chemist and a molecular modeler at Peptide Therapeutics and Medivir. He joined Cresset in 2002 as Chief Applications Scientist, applying Cresset technology to solve the problems of our clients. He has been instrumental in developing the easy-to-use scientific software that characterizes a Cresset product today. In 2021, Tim was pivotal in the founding of Torx Software, a Cresset joint venture with Elixir software. In 2024, Tim became CEO of Cresset, taking responsibility for overseeing the company's business strategy, activities, and operations. Central to Tim’s career has been the implementation of accessible, innovative science and technology that enhances drug discovery IP, streamlines processes, and shortens development timelines.